The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
 
Johan W.K. Chan
Honoraria - Merck (Inst); Pfizer (Inst)
Consulting or Advisory Role - MSD Oncology (Inst)
 
Daniel Peh
No Relationships to Disclose
 
Wei Chong Tan
No Relationships to Disclose
 
Hui Shan Tan
No Relationships to Disclose
 
Quan Sing Ng
No Relationships to Disclose
 
Tanujaa Rajasekaran
Honoraria - MSD; Novartis
Consulting or Advisory Role - Eisai; Ipsen
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen
 
Yi Lin Teh
Consulting or Advisory Role - Novartis
 
Stephanie Saw
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - MSD
 
Wan Ling Tan
Honoraria - Amgen; Merck; Novartis
Travel, Accommodations, Expenses - BMS; Boehringer Ingelheim; DKSH
 
Gillianne Lai
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen
Research Funding - AstraZeneca (Inst); Bristol-Myers-Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
 
Amit Jain
No Relationships to Disclose
 
Ravindran Kanesvaran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen; MSD Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MSD Oncology; Novartis; pfizer
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology